Table of Contents

company-logo

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Amphastar Pharmaceuticals Dividend Announcement

• Amphastar Pharmaceuticals announced a annually dividend of $0.30 per ordinary share which will be made payable on 2010-06-30. Ex dividend date: 2010-06-11
• Amphastar Pharmaceuticals's trailing twelve-month (TTM) dividend yield is -%

Amphastar Pharmaceuticals Dividend History

Ex-Div dateDividend amountDividend typePay date
2010-06-11$0.30annually2010-06-30
2009-06-11$0.30annually2009-06-30

Amphastar Pharmaceuticals Dividend per year

Amphastar Pharmaceuticals Dividend Yield

Amphastar Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Amphastar Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Amphastar Pharmaceuticals Financial Ratios

P/E ratio13.51
PEG ratio0.01
P/B ratio2.93
ROE22.92%
Payout ratio0.00%
Current ratio3.43
Quick ratio2.61
Cash Ratio1.21

Amphastar Pharmaceuticals Dividend FAQ

Does Amphastar Pharmaceuticals stock pay dividends?
Amphastar Pharmaceuticals does not currently pay dividends to its shareholders.
Has Amphastar Pharmaceuticals ever paid a dividend?
No, Amphastar Pharmaceuticals has no a history of paying dividends to its shareholders. Amphastar Pharmaceuticals is not known for its dividend payments.
Why doesn't Amphastar Pharmaceuticals pay dividends?
There are several potential reasons why Amphastar Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Amphastar Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Amphastar Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Amphastar Pharmaceuticals a dividend aristocrat?
Amphastar Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Amphastar Pharmaceuticals a dividend king?
Amphastar Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Amphastar Pharmaceuticals a dividend stock?
No, Amphastar Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Amphastar Pharmaceuticals stocks?
To buy Amphastar Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Amphastar Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.